Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: The case of Yaoundé-Cameroon
The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IH...
Saved in:
Published in | Journal of the neurological sciences Vol. 285; no. 1; pp. 149 - 153 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
15.10.2009
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaoundé [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008;49(4):393–397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD.
A cross-sectional study was conducted in Yaoundé, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score ≤
10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at
P
≤
0.05. A binary logistic regression was used to determine independent risk factors.
The following factors were independent predictors of HAND: advanced clinical stage (OR
=
7.43,
P
=
0.001), low CD4 count especially CD4
≤
200 cells/µL (OR
=
4.88,
P
=
0.045) and low hemoglobin concentration (OR
=
1.16,
P
=
0.048).
This first study of the risk factors for HAND in Yaoundé-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours. |
---|---|
AbstractList | AbstractBackgroundThe prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaoundé [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008;49(4):393–397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD. Patients and methodsA cross-sectional study was conducted in Yaoundé, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score ≤ 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P≤ 0.05. A binary logistic regression was used to determine independent risk factors. ResultsThe following factors were independent predictors of HAND: advanced clinical stage (OR = 7.43, P= 0.001), low CD4 count especially CD4 ≤ 200 cells/µL (OR = 4.88, P= 0.045) and low hemoglobin concentration (OR = 1.16, P= 0.048). ConclusionThis first study of the risk factors for HAND in Yaoundé-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours. The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaoundé [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008;49(4):393-397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD.BACKGROUNDThe prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaoundé [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008;49(4):393-397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD.A cross-sectional study was conducted in Yaoundé, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score < or = 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P < or = 0.05. A binary logistic regression was used to determine independent risk factors.PATIENTS AND METHODSA cross-sectional study was conducted in Yaoundé, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score < or = 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P < or = 0.05. A binary logistic regression was used to determine independent risk factors.The following factors were independent predictors of HAND: advanced clinical stage (OR=7.43, P=0.001), low CD4 count especially CD4 < or = 200 cells/microL (OR=4.88, P=0.045) and low hemoglobin concentration (OR=1.16, P=0.048).RESULTSThe following factors were independent predictors of HAND: advanced clinical stage (OR=7.43, P=0.001), low CD4 count especially CD4 < or = 200 cells/microL (OR=4.88, P=0.045) and low hemoglobin concentration (OR=1.16, P=0.048).This first study of the risk factors for HAND in Yaoundé-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours.CONCLUSIONThis first study of the risk factors for HAND in Yaoundé-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours. The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaounde [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaounde-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008; 49(4):393-397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD. Patients and methods - A cross-sectional study was conducted in Yaounde, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score <= 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P <= 0.05. A binary logistic regression was used to determine independent risk factors. Results - The following factors were independent predictors of HAND: advanced clinical stage (OR = 7.43, P = 0.001), low CD4 count especially CD4 <= 200 cells/kL (OR = 4.88, P = 0.045) and low hemoglobin concentration (OR = 1.16, P = 0.048). Conclusion - This first study of the risk factors for HAND in Yaounde-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours. The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaoundé [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008;49(4):393-397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD. A cross-sectional study was conducted in Yaoundé, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score < or = 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P < or = 0.05. A binary logistic regression was used to determine independent risk factors. The following factors were independent predictors of HAND: advanced clinical stage (OR=7.43, P=0.001), low CD4 count especially CD4 < or = 200 cells/microL (OR=4.88, P=0.045) and low hemoglobin concentration (OR=1.16, P=0.048). This first study of the risk factors for HAND in Yaoundé-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours. The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The prevalence as well as risk factors for HAD are not well known in sub-Saharan Africa (SSA). We have shown that the International HIV Dementia Scale (IHDS) is a useful screening tool for HAND in Yaoundé [Njamnshi AK, Djientcheu VdP, Fonsah JY, Yepnjio FN, Njamnshi DM, Muna WFT. The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon. Journal of Acquired Immune Deficiency Syndromes 2008;49(4):393–397], but no study in Cameroon has yet investigated the risk factors for HAND or HAD. A cross-sectional study was conducted in Yaoundé, the capital of Cameroon from September to December 2006. One hundred and eighty-five HIV-positive subjects were included. Diagnosis of HAND was done using the IHDS with a score ≤ 10 considered as abnormal. Age, sex, level of education, IV drug use, body mass index (BMI), CDC clinical stage, CD4 counts, hemoglobin levels, administration of highly active antiretroviral therapy (HAART) and type of regimen used, were considered in univariate analysis, with level of significance set at P ≤ 0.05. A binary logistic regression was used to determine independent risk factors. The following factors were independent predictors of HAND: advanced clinical stage (OR = 7.43, P = 0.001), low CD4 count especially CD4 ≤ 200 cells/µL (OR = 4.88, P = 0.045) and low hemoglobin concentration (OR = 1.16, P = 0.048). This first study of the risk factors for HAND in Yaoundé-Cameroon shows findings similar to those described in other studies. These results call for rapid action by policy makers to include HAND prevention strategies such as providing early universal access to HAART based on these risk factors, in the management of HIV patients at risk of HAND in resource-limited settings of SSA like ours. |
Author | Dema, F. Muna, W.F.T. Angwafor, S.A. Kouanfack, C. Kanmogne, G.D. Zoung-Kanyi Bissek, A.C. Lekoubou, A.Z. Djientcheu, V. de P. Kuate, C.T. Tabah, E.N. Yepnjio, F.N. Njamnshi, A.K. Njamnshi, D.M. Ongolo-Zogo, P. Fonsah, J.Y. |
Author_xml | – sequence: 1 givenname: A.K. surname: Njamnshi fullname: Njamnshi, A.K. email: aknjamnshi@yahoo.co.uk organization: Neurology Department, Central Hospital & Faculty of Med. & Biomed. Sciences (FMBS), University of Yaounde 1 (UY1), BP 25625, Yaounde, Cameroon – sequence: 2 givenname: A.C. surname: Zoung-Kanyi Bissek fullname: Zoung-Kanyi Bissek, A.C. organization: Dept. of Int. Med. & Specialties, FMBS, UY1, Yaounde, Cameroon – sequence: 3 givenname: P. surname: Ongolo-Zogo fullname: Ongolo-Zogo, P. organization: Medical Imaging Dept, Central Hospital, Yaounde & FMBS, UY1, Cameroon – sequence: 4 givenname: E.N. surname: Tabah fullname: Tabah, E.N. organization: Neurology Dept, Central Hospital, Yaounde, Cameroon – sequence: 5 givenname: A.Z. surname: Lekoubou fullname: Lekoubou, A.Z. organization: Neurology Dept, Central Hospital, Yaounde, Cameroon – sequence: 6 givenname: F.N. surname: Yepnjio fullname: Yepnjio, F.N. organization: Fann Teaching Hospital, Dakar & Neurology Dept, Central Hospital, Yaounde, Cameroon – sequence: 7 givenname: J.Y. surname: Fonsah fullname: Fonsah, J.Y. organization: Neurology Dept, Central Hospital, Yaounde, Cameroon – sequence: 8 givenname: C.T. surname: Kuate fullname: Kuate, C.T. organization: Neurology Department, Central Hospital & Faculty of Med. & Biomed. Sciences (FMBS), University of Yaounde 1 (UY1), BP 25625, Yaounde, Cameroon – sequence: 9 givenname: S.A. surname: Angwafor fullname: Angwafor, S.A. organization: Neurology Dept, Central Hospital, Yaounde, Cameroon – sequence: 10 givenname: F. surname: Dema fullname: Dema, F. organization: Neurology Dept, Central Hospital, Yaounde, Cameroon – sequence: 11 givenname: D.M. surname: Njamnshi fullname: Njamnshi, D.M. organization: HIV Day Care Unit, Central Hospital, Yaounde, Cameroon – sequence: 12 givenname: C. surname: Kouanfack fullname: Kouanfack, C. organization: HIV Day Care Unit, Central Hospital, Yaounde, Cameroon – sequence: 13 givenname: V. de P. surname: Djientcheu fullname: Djientcheu, V. de P. organization: Neurology Dept, Central Hospital, Yaounde, Cameroon – sequence: 14 givenname: W.F.T. surname: Muna fullname: Muna, W.F.T. organization: Dept. of Int. Med. & Specialties, FMBS, UY1, Yaounde, Cameroon – sequence: 15 givenname: G.D. surname: Kanmogne fullname: Kanmogne, G.D. organization: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, USA |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22347994$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19631349$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks1uEzEUhS1URNPAA7BB3vC3mGCPPT8uUqUo_KRSBRItCFaWx77TOJ3YxZ6J1EfiOXgxZpoQQSXCygufc3zu9XeEDpx3gNBjSiaU0PzVcrJ0cZISIiYknxDO7qERLYsyycqSHaARIWmaZJR8PURHMS4JIXlZigfokIqcUcbFCLWfbLzCtdKtDxHXPuD56ZdExei1VS0Y7KALXvtLZ1u7Bmxs9MFAr30xn3548xJbh2NXJedqoYJyeFoHq9UxvlgA1ioC9jX-pnznzM8fyUytIHjvHqL7tWoiPNqeY_T53duL2Tw5-_j-dDY9S3TORJuUXNSaqJpDTaracMU1FbQEXfECBAVIK8OoKQqVVkWWFpBDYSpq8ozVhKmCjdHJJve6q1ZgNLg2qEZeB7tS4UZ6ZeXfN84u5KVfSy5ILjjrA55vA4L_3kFs5cpGDU2jHPguyoJxwmmWl73y2V5lSspU5DzrhU_-7LQr8_tLesHTrUBFrZq636q2cadLU8YL0Zcbo2Kj08HHGKCW2raqtX4YxTaSEjlAIpeyh0QOkEiSS3I7Fb3j3JXY43m98UD_X2sLQUZtwWkwNoBupfF2r_vkjls31vWgNFdwA3Hpu-B6ECSVMZVEng_gDtwSMSB7u17x74D_PP4LMpX-jA |
CODEN | JNSCAG |
CitedBy_id | crossref_primary_10_1038_s41598_018_20271_x crossref_primary_10_1016_j_ejphar_2015_03_018 crossref_primary_10_1074_jbc_M111_262543 crossref_primary_10_1111_tmi_12449 crossref_primary_10_1155_2019_5173289 crossref_primary_10_1097_QAI_0000000000002242 crossref_primary_10_1097_QAI_0000000000002385 crossref_primary_10_1186_s40249_019_0544_6 crossref_primary_10_1016_j_ajp_2017_05_003 crossref_primary_10_1007_s11065_021_09527_y crossref_primary_10_1007_s13365_012_0097_y crossref_primary_10_1007_s10461_011_9988_9 crossref_primary_10_1016_j_drugalcdep_2013_12_021 crossref_primary_10_1186_1471_2377_10_60 crossref_primary_10_1002_alz_12432 crossref_primary_10_1111_hiv_12979 crossref_primary_10_3389_fnana_2017_00096 crossref_primary_10_1186_1471_2458_14_653 crossref_primary_10_17159_sajs_2021_8575 crossref_primary_10_1016_j_ijid_2013_06_011 crossref_primary_10_1038_s41598_020_70981_4 crossref_primary_10_1093_ije_dyt198 crossref_primary_10_1017_S1355617720000120 crossref_primary_10_1111_hiv_12137 crossref_primary_10_1007_s11604_021_01150_4 crossref_primary_10_1258_ijsa_2010_009554 crossref_primary_10_1017_S1041610219000413 crossref_primary_10_1136_bmjopen_2011_000662 crossref_primary_10_1155_2015_486960 crossref_primary_10_1080_03630242_2013_767301 crossref_primary_10_1111_j_1468_1293_2012_01043_x crossref_primary_10_1007_s11481_013_9505_1 crossref_primary_10_1155_2019_8306823 crossref_primary_10_1097_NMD_0000000000000962 crossref_primary_10_4269_ajtmh_22_0234 crossref_primary_10_1186_1471_2377_13_86 crossref_primary_10_2217_fvl_11_71 crossref_primary_10_7759_cureus_18776 crossref_primary_10_1186_s12889_023_15935_x crossref_primary_10_3390_pathogens13070568 crossref_primary_10_1097_QAI_0000000000000898 |
Cites_doi | 10.1097/00002030-199305000-00012 10.1097/00002030-199808000-00002 10.1212/WNL.53.4.782 10.1080/13550280701829793 10.1097/QAI.0b013e318183a9df 10.1371/journal.pmed.1000066 10.1080/13550280590952790 10.1097/00002030-199910010-00011 10.1176/jnp.15.2.208 10.3109/13550280009006385 10.1097/00042560-200109010-00004 10.1001/archpedi.159.7.651 10.1212/01.wnl.0000225183.74521.72 10.1212/WNL.52.3.607 10.1097/00042560-199601010-00005 10.1080/13550280290049615 10.1212/01.wnl.0000252811.48891.6d 10.1089/088922204323087723 10.1186/1758-2652-12-5 10.1212/WNL.43.11.2245 10.1212/01.wnl.0000339042.96109.86 10.1097/00126334-200405010-00003 10.1056/NEJMp0902820 10.1212/01.WNL.0000287431.88658.8b 10.1592/phco.23.14.1475.31949 10.1176/jnp.17.2.180 10.1212/01.WNL.0000134665.58343.8D |
ContentType | Journal Article |
Copyright | 2009 Elsevier B.V. Elsevier B.V. 2015 INIST-CNRS |
Copyright_xml | – notice: 2009 Elsevier B.V. – notice: Elsevier B.V. – notice: 2015 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 7TK 7U9 H94 7X8 5PM |
DOI | 10.1016/j.jns.2009.06.043 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Neurosciences Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Immunology Abstracts Virology and AIDS Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1878-5883 |
EndPage | 153 |
ExternalDocumentID | PMC4906943 19631349 22347994 10_1016_j_jns_2009_06_043 S0022510X09006868 1_s2_0_S0022510X09006868 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | Africa Africa South of the Sahara Cameroon |
GeographicLocations_xml | – name: Cameroon – name: Africa South of the Sahara |
GrantInformation_xml | – fundername: NIMH NIH HHS grantid: R21 MH080611 – fundername: NIMH NIH HHS grantid: R01 MH094160 – fundername: NIMH NIH HHS grantid: MH080611 |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29L 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABFRF ABGSF ABIVO ABJNI ABLJU ABMAC ABMZM ABTEW ABUDA ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEFWE AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRLJ AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDW HMK HMO HMQ HVGLF HZ~ IHE J1W KOM L7B LX8 M29 M2V M41 MO0 MOBAO N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SNS SPCBC SSH SSN SSU SSZ T5K WUQ X7M Z5R ZGI ZXP ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AADPK AAIAV ABLVK ABYKQ AHPSJ AJBFU DOVZS EFLBG LCYCR ZA5 AAYXX AGRNS CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 7TK 7U9 H94 7X8 5PM |
ID | FETCH-LOGICAL-c639t-849fc0af4ef0bfd4a4c1918ecb47e91ee2bd31d77a2b7527e6e7db1d653f03a73 |
IEDL.DBID | AIKHN |
ISSN | 0022-510X 1878-5883 |
IngestDate | Thu Aug 21 13:40:32 EDT 2025 Fri Jul 11 03:25:46 EDT 2025 Fri Jul 11 09:03:45 EDT 2025 Mon Jul 21 06:07:20 EDT 2025 Mon Jul 21 09:13:55 EDT 2025 Thu Apr 24 23:06:38 EDT 2025 Tue Jul 01 01:13:49 EDT 2025 Fri Feb 23 02:30:02 EST 2024 Sun Feb 23 10:18:46 EST 2025 Tue Aug 26 16:47:57 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | HIV/AIDS SSA Cameroon IHDS Risk factors Dementia Immunopathology Nervous system diseases Cognitive disorder AIDS Immune deficiency Hand Infection Viral disease Risk factor Degenerative disease |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c639t-849fc0af4ef0bfd4a4c1918ecb47e91ee2bd31d77a2b7527e6e7db1d653f03a73 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 19631349 |
PQID | 20829645 |
PQPubID | 23462 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4906943 proquest_miscellaneous_734041568 proquest_miscellaneous_20829645 pubmed_primary_19631349 pascalfrancis_primary_22347994 crossref_citationtrail_10_1016_j_jns_2009_06_043 crossref_primary_10_1016_j_jns_2009_06_043 elsevier_sciencedirect_doi_10_1016_j_jns_2009_06_043 elsevier_clinicalkeyesjournals_1_s2_0_S0022510X09006868 elsevier_clinicalkey_doi_10_1016_j_jns_2009_06_043 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-10-15 |
PublicationDateYYYYMMDD | 2009-10-15 |
PublicationDate_xml | – month: 10 year: 2009 text: 2009-10-15 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: Netherlands |
PublicationTitle | Journal of the neurological sciences |
PublicationTitleAlternate | J Neurol Sci |
PublicationYear | 2009 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Tozzi, Narciso, Galgani, Sette, Balestra, Gerace, Pau, Pigorini, Volpini, Camporiondo, Giulianelli, Visco (bib11) 1993; 7 Robertson, Kopnisky, Hakim, Merry, Nakasujja, Hall, Traore, Sacktor, Clifford, Newton, Van Rie, Holding, Clements, Zink, Mielke, Hosseinipour, Lalloo, Amod, Marra, Evans, Liner (bib14) 2008; 14 Ford, Mills, Calmy (bib30) 2009; 360 Ongolo-Zogo, Amana, Njamnshi, Magny-Tiam, Kamga, Gonsu (bib3) 2000; 2 Njamnshi, Djientcheu, Fonsah, Yepnjio, Njamnshi, Muna (bib2) 2008; 49 Heaton, Franklin, Clifford (bib29) 2009 Shanbhag, Rutstein, Zaoutis, Zhao, Chao, Radcliffe (bib10) 2005; 159 Evers, Rahmann, Schwaag, Frese, Reichelt, Husstedt (bib28) 2004; 20 Wong, Robertson, Nakasujja, Skolasky, Musisi, Katabira, McArthur, Ronald, Sacktor (bib18) 2007; 68 Valcour, Shikuma, Shiramizu, Watters, Poff, Selnes, Holck, Grove, Sacktor (bib34) 2004; 63 Sacktor, Wong, Nakasujja, Skolasky, Selnes, Musisi, Robertson, McArthur, Ronald, Katabira (bib19) 2005; 19 Brokering, Qaqish (bib21) 2003; 23 Chiesi, Vella, Dally, Pedersen, Danner, Johnson, Schwander, Goebel, Glauser, Antunes (bib16) 1996; 11 Ferrando, van Gorp, McElhiney, Goggin, Sewell, Rabkin (bib22) 1998; 12 Pitt, Myer, Wood (bib32) 2009; 12 Tozzi, Balestra, Lorenzini, Bellagamba, Galgani, Corpologo, Vlassi, Larussa, Zaccareli, Noto, Visco-Comandini, Giulianelli, Ippolito, Antinori, Narciso (bib15) 2005; 11 Antinori, Arendt, Becker, Brew, Byrd, Cherner, Clifford, Cinque, Epstein, Goodkin, Gisslen, Grant, Heaton, Joseph, Marder, Marra, McArthur, Nunn, Price, Pulliam, Robertson, Sacktor, Valcour, Wojna (bib35) 2007; 69 Childs, Lyles, Selnes, Chen, Miller, Cohen, Becker, Mellors, McArthur (bib24) 1999; 52 McArthur, Hoover, Bacellar, Miller, Cohen, Becker, Graham, McArthur, Selnes, Jacobson (bib17) 1993; 43 Brinkhof, Boulle, Weigel, Messou, Mathers, Orrell, Dabis, Pascoe, Egger (bib31) 2009; 6 Sacktor, Nakasujja, Skolasky (bib9) 2006; 67 Dongmo, Njamnshi, Kaptue, Tenaguem, Djientcheu V de, Ongolo-Zogo, Yepnjio (bib4) 2003; 12 Ferrando, Rabkin, Van Gorp, Lin, McElhiney (bib5) 2003; 15 Sacktor, Nakasujja, Skolasky, Robertson, Musisi, Ronald, Katabira, Clifford (bib27) 2009; 72 UNAIDS Report on the Global AIDS Epidemic, July 2008;2008. Tozzi (bib26) 2004; 507 Bryden (bib20) 1977; 15 Chang, Ernst, Leonido-Yee, Witt, Speck, Walot, Miller (bib23) 1999; 53 Sacktor, Skolasky, Lyles, Esposito, Selnes, McArthur (bib8) 2000; 6 Tozzi, Balestra, Galgani, Narciso, Ferri, Sebastiani, D'Amato, Affricano, Pigorini, Pau, De Felici, Benedetto (bib12) 1999; 3 Sacktor, McDermott, Marder, Schifitto, Selnes, McArthur, Stern, Albert, Palumbo, Kieburtz, De Marcaida, Cohen, Epstein (bib25) 2002; 8 Robertson, Robertson, Ford, Watson, Fiscus, Harp, Hall (bib6) 2004; 36 Saavedra-Lozano, Ramos, Sanz, Navarro, De Jose, Martin-Fontelos, Mellado, Leal, Rodriguez, Luque, Madison, Irlbeck, Lanier, Ramilo (bib7) 2006; 1152 Kissel, Pukay-Martin, Bornstein (bib33) 2005; 17 Tozzi, Balestra, Galgani, Narciso, Sampaolesi, Antinori, Giulianelli, Serraino, Ippolito (bib13) 2001; 28 Dongmo (10.1016/j.jns.2009.06.043_bib4) 2003; 12 Ongolo-Zogo (10.1016/j.jns.2009.06.043_bib3) 2000; 2 Brokering (10.1016/j.jns.2009.06.043_bib21) 2003; 23 Tozzi (10.1016/j.jns.2009.06.043_bib11) 1993; 7 Kissel (10.1016/j.jns.2009.06.043_bib33) 2005; 17 Bryden (10.1016/j.jns.2009.06.043_bib20) 1977; 15 Sacktor (10.1016/j.jns.2009.06.043_bib27) 2009; 72 Shanbhag (10.1016/j.jns.2009.06.043_bib10) 2005; 159 Heaton (10.1016/j.jns.2009.06.043_bib29) 2009 Tozzi (10.1016/j.jns.2009.06.043_bib12) 1999; 3 Sacktor (10.1016/j.jns.2009.06.043_bib9) 2006; 67 Valcour (10.1016/j.jns.2009.06.043_bib34) 2004; 63 Childs (10.1016/j.jns.2009.06.043_bib24) 1999; 52 Tozzi (10.1016/j.jns.2009.06.043_bib13) 2001; 28 Njamnshi (10.1016/j.jns.2009.06.043_bib2) 2008; 49 Saavedra-Lozano (10.1016/j.jns.2009.06.043_bib7) 2006; 1152 Ford (10.1016/j.jns.2009.06.043_bib30) 2009; 360 Sacktor (10.1016/j.jns.2009.06.043_bib19) 2005; 19 Chiesi (10.1016/j.jns.2009.06.043_bib16) 1996; 11 Antinori (10.1016/j.jns.2009.06.043_bib35) 2007; 69 Ferrando (10.1016/j.jns.2009.06.043_bib22) 1998; 12 Evers (10.1016/j.jns.2009.06.043_bib28) 2004; 20 McArthur (10.1016/j.jns.2009.06.043_bib17) 1993; 43 Chang (10.1016/j.jns.2009.06.043_bib23) 1999; 53 Ferrando (10.1016/j.jns.2009.06.043_bib5) 2003; 15 Wong (10.1016/j.jns.2009.06.043_bib18) 2007; 68 Sacktor (10.1016/j.jns.2009.06.043_bib8) 2000; 6 Pitt (10.1016/j.jns.2009.06.043_bib32) 2009; 12 Robertson (10.1016/j.jns.2009.06.043_bib14) 2008; 14 Sacktor (10.1016/j.jns.2009.06.043_bib25) 2002; 8 Brinkhof (10.1016/j.jns.2009.06.043_bib31) 2009; 6 10.1016/j.jns.2009.06.043_bib1 Robertson (10.1016/j.jns.2009.06.043_bib6) 2004; 36 Tozzi (10.1016/j.jns.2009.06.043_bib15) 2005; 11 Tozzi (10.1016/j.jns.2009.06.043_bib26) 2004; 507 |
References_xml | – volume: 12 start-page: F65 year: 1998 end-page: F70 ident: bib22 article-title: Highly active anti-retroviral treatment in HIV infection: benefits for neuropsychological function publication-title: AIDS – volume: 20 start-page: 483 year: 2004 end-page: 491 ident: bib28 article-title: Prevention of AIDS dementia by HAART does not depend on cerebrospinal fluid drug penetrance publication-title: AIDS Research and Human Retroviruses – volume: 36 start-page: 562 year: 2004 end-page: 566 ident: bib6 article-title: Highly active antiretroviral therapy improves neurocognitive functioning publication-title: J Acquir Immune Defic Syndr – volume: 28 start-page: 19 year: 2001 end-page: 27 ident: bib13 article-title: Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years publication-title: J Acquir Immune Defic Syndr – volume: 8 start-page: 136 year: 2002 end-page: 142 ident: bib25 article-title: HIV-associated cognitive impairment before and after the advent of combination therapy publication-title: J NeuroVirol – volume: 6 start-page: 84 year: 2000 end-page: 88 ident: bib8 article-title: Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors publication-title: J NeuroVirol – volume: 53 start-page: 782 year: 1999 end-page: 789 ident: bib23 article-title: Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia publication-title: Neurology – volume: 1152 year: 2006 ident: bib7 article-title: Salvage therapy with abacavir and other reverse transcriptase inhibitors for human imunodeficiency-associated encephalopathy publication-title: Pediatr Infect Dis J 25, 1142– – start-page: 2009 year: 2009 ident: bib29 article-title: HIV-associated neurocognitive impairment remains prevalent in the era of combination ART: the CHARTER study publication-title: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections – reference: UNAIDS Report on the Global AIDS Epidemic, July 2008;2008. – volume: 15 year: 1977 ident: bib20 article-title: Measuring handedness with questionnaires publication-title: Neuropsychologia – volume: 360 start-page: 1808 year: 2009 end-page: 1810 ident: bib30 article-title: Rationing antiretroviral therapy in Africa—treating too few, too late publication-title: N Engl J Med – volume: 11 start-page: 39 year: 1996 end-page: 44 ident: bib16 article-title: Epidemiology of AIDS Dementia Complex in Europe. AIDS in Europe Study Group publication-title: J Acquir immune Defic Syndr Hum Retrovirol – volume: 7 start-page: 683 year: 1993 end-page: 692 ident: bib11 article-title: Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex publication-title: AIDS – volume: 11 start-page: 265 year: 2005 end-page: 273 ident: bib15 article-title: Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996–2002: results from an urban observational cohort publication-title: J Neurovirol – volume: 17 start-page: 180 year: 2005 end-page: 184 ident: bib33 article-title: The relationship between age and cognitive function in HIV-infected men publication-title: J Neuropsychiatry Clin Neurosci – volume: 15 start-page: 208 year: 2003 end-page: 214 ident: bib5 article-title: Longitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection publication-title: J Neuropsychiatry Clin Neurosci – volume: 23 start-page: 1475 year: 2003 end-page: 1485 ident: bib21 article-title: Management of anemia of chronic disease in patients with the human immunodeficiency virus publication-title: Pharmacotherapy – volume: 69 start-page: 1789 year: 2007 end-page: 1799 ident: bib35 article-title: Updated research nosology for HIV-associated neurocognitive disorders publication-title: Neurology – volume: 159 start-page: 651 year: 2005 end-page: 656 ident: bib10 article-title: Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy publication-title: Arch Pediatr Adolesc Med – volume: 507 year: 2004 ident: bib26 article-title: Neurocognitive impairment and survival in HIV-positive patients treated with HAART: results from an urban observational cohort publication-title: Eleventh Conference on Retroviruses and Opportunistic Infections, San Francisco, abstract – volume: 6 start-page: 1 year: 2009 end-page: 10.e1000066 ident: bib31 article-title: International Epidemiological Databases to Evaluate AIDS (IeDEA). Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality publication-title: PLoS Med – volume: 68 start-page: 350 year: 2007 end-page: 355 ident: bib18 article-title: Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa publication-title: Neurology – volume: 12 start-page: 5 year: 2009 ident: bib32 article-title: Quality of life and the impact of drug toxicities in a South African community antiretroviral programme publication-title: Journal of the International AIDS Society – volume: 63 start-page: 822 year: 2004 end-page: 827 ident: bib34 article-title: Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort publication-title: Neurology – volume: 2 start-page: 17 year: 2000 end-page: 22 ident: bib3 article-title: Aspects cliniques et scanographiques des lésions cérébrales chez l'adulte camerounais VIH positif: à propos de 94 cas publication-title: Health Sci Dis. – volume: 12 start-page: 11 year: 2003 end-page: 12 ident: bib4 article-title: Aspects cliniques et étiologiques des encéphalopathies chez le sujet VIH positif à Yaoundé publication-title: Journal Camerounais de Médecine. – volume: 52 start-page: 607 year: 1999 end-page: 613 ident: bib24 article-title: Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy publication-title: Neurology – volume: 43 start-page: 2245 year: 1993 end-page: 2252 ident: bib17 article-title: Dementia in AIDS patients: incidence and risk factors publication-title: Neurology – volume: 72 start-page: 165 year: 2009 end-page: 170 ident: bib27 article-title: Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda publication-title: Neurology – volume: 49 start-page: 393 year: 2008 end-page: 397 ident: bib2 article-title: The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon publication-title: Journal of Acquired Immune Deficiency Syndromes – volume: 19 start-page: 1367 year: 2005 end-page: 1374 ident: bib19 article-title: The International HIV Dementia scale: a new rapid screening test for HIV dementia publication-title: AIDS – volume: 14 start-page: 89 year: 2008 end-page: 101 ident: bib14 article-title: On behalf of the second Assessment of NeuroAIDS in Africa Conference Participants publication-title: J Neurovirol – volume: 67 start-page: 311 year: 2006 end-page: 314 ident: bib9 article-title: Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa publication-title: Neurology – volume: 3 start-page: 1889 year: 1999 end-page: 1897 ident: bib12 article-title: Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment publication-title: AIDS – volume: 7 start-page: 683 issue: 5 year: 1993 ident: 10.1016/j.jns.2009.06.043_bib11 article-title: Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex publication-title: AIDS doi: 10.1097/00002030-199305000-00012 – volume: 12 start-page: F65 issue: 8 year: 1998 ident: 10.1016/j.jns.2009.06.043_bib22 article-title: Highly active anti-retroviral treatment in HIV infection: benefits for neuropsychological function publication-title: AIDS doi: 10.1097/00002030-199808000-00002 – volume: 53 start-page: 782 issue: 4 year: 1999 ident: 10.1016/j.jns.2009.06.043_bib23 article-title: Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia publication-title: Neurology doi: 10.1212/WNL.53.4.782 – volume: 14 start-page: 89 issue: 2 year: 2008 ident: 10.1016/j.jns.2009.06.043_bib14 article-title: On behalf of the second Assessment of NeuroAIDS in Africa Conference Participants publication-title: J Neurovirol doi: 10.1080/13550280701829793 – volume: 49 start-page: 393 issue: 4 year: 2008 ident: 10.1016/j.jns.2009.06.043_bib2 article-title: The IHDS is a useful screening tool for HAD/Cognitive Impairment in HIV-infected adults in Yaoundé-Cameroon publication-title: Journal of Acquired Immune Deficiency Syndromes doi: 10.1097/QAI.0b013e318183a9df – volume: 6 start-page: 1 issue: 4 year: 2009 ident: 10.1016/j.jns.2009.06.043_bib31 article-title: International Epidemiological Databases to Evaluate AIDS (IeDEA). Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality publication-title: PLoS Med doi: 10.1371/journal.pmed.1000066 – volume: 11 start-page: 265 year: 2005 ident: 10.1016/j.jns.2009.06.043_bib15 article-title: Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996–2002: results from an urban observational cohort publication-title: J Neurovirol doi: 10.1080/13550280590952790 – volume: 3 start-page: 1889 issue: 14 year: 1999 ident: 10.1016/j.jns.2009.06.043_bib12 article-title: Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment publication-title: AIDS doi: 10.1097/00002030-199910010-00011 – volume: 15 start-page: 208 year: 2003 ident: 10.1016/j.jns.2009.06.043_bib5 article-title: Longitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection publication-title: J Neuropsychiatry Clin Neurosci doi: 10.1176/jnp.15.2.208 – ident: 10.1016/j.jns.2009.06.043_bib1 – volume: 6 start-page: 84 year: 2000 ident: 10.1016/j.jns.2009.06.043_bib8 article-title: Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors publication-title: J NeuroVirol doi: 10.3109/13550280009006385 – volume: 2 start-page: 17 year: 2000 ident: 10.1016/j.jns.2009.06.043_bib3 article-title: Aspects cliniques et scanographiques des lésions cérébrales chez l'adulte camerounais VIH positif: à propos de 94 cas publication-title: Health Sci Dis. – volume: 28 start-page: 19 year: 2001 ident: 10.1016/j.jns.2009.06.043_bib13 article-title: Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years publication-title: J Acquir Immune Defic Syndr doi: 10.1097/00042560-200109010-00004 – volume: 12 start-page: 11 issue: 1 year: 2003 ident: 10.1016/j.jns.2009.06.043_bib4 article-title: Aspects cliniques et étiologiques des encéphalopathies chez le sujet VIH positif à Yaoundé publication-title: Journal Camerounais de Médecine. – volume: 159 start-page: 651 year: 2005 ident: 10.1016/j.jns.2009.06.043_bib10 article-title: Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy publication-title: Arch Pediatr Adolesc Med doi: 10.1001/archpedi.159.7.651 – volume: 67 start-page: 311 issue: 2 year: 2006 ident: 10.1016/j.jns.2009.06.043_bib9 article-title: Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa publication-title: Neurology doi: 10.1212/01.wnl.0000225183.74521.72 – volume: 52 start-page: 607 issue: 3 year: 1999 ident: 10.1016/j.jns.2009.06.043_bib24 article-title: Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy publication-title: Neurology doi: 10.1212/WNL.52.3.607 – volume: 11 start-page: 39 issue: 1 year: 1996 ident: 10.1016/j.jns.2009.06.043_bib16 article-title: Epidemiology of AIDS Dementia Complex in Europe. AIDS in Europe Study Group publication-title: J Acquir immune Defic Syndr Hum Retrovirol doi: 10.1097/00042560-199601010-00005 – volume: 8 start-page: 136 issue: 2 year: 2002 ident: 10.1016/j.jns.2009.06.043_bib25 article-title: HIV-associated cognitive impairment before and after the advent of combination therapy publication-title: J NeuroVirol doi: 10.1080/13550280290049615 – volume: 68 start-page: 350 issue: 5 year: 2007 ident: 10.1016/j.jns.2009.06.043_bib18 article-title: Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa publication-title: Neurology doi: 10.1212/01.wnl.0000252811.48891.6d – volume: 20 start-page: 483 issue: 5 year: 2004 ident: 10.1016/j.jns.2009.06.043_bib28 article-title: Prevention of AIDS dementia by HAART does not depend on cerebrospinal fluid drug penetrance publication-title: AIDS Research and Human Retroviruses doi: 10.1089/088922204323087723 – volume: 12 start-page: 5 year: 2009 ident: 10.1016/j.jns.2009.06.043_bib32 article-title: Quality of life and the impact of drug toxicities in a South African community antiretroviral programme publication-title: Journal of the International AIDS Society doi: 10.1186/1758-2652-12-5 – volume: 15 issue: 4–5 year: 1977 ident: 10.1016/j.jns.2009.06.043_bib20 article-title: Measuring handedness with questionnaires publication-title: Neuropsychologia – volume: 43 start-page: 2245 issue: 11 year: 1993 ident: 10.1016/j.jns.2009.06.043_bib17 article-title: Dementia in AIDS patients: incidence and risk factors publication-title: Neurology doi: 10.1212/WNL.43.11.2245 – volume: 72 start-page: 165 year: 2009 ident: 10.1016/j.jns.2009.06.043_bib27 article-title: Benefits and risks of stavudine therapy for HIV-associated neurologic complications in Uganda publication-title: Neurology doi: 10.1212/01.wnl.0000339042.96109.86 – start-page: 2009 year: 2009 ident: 10.1016/j.jns.2009.06.043_bib29 article-title: HIV-associated neurocognitive impairment remains prevalent in the era of combination ART: the CHARTER study – volume: 36 start-page: 562 year: 2004 ident: 10.1016/j.jns.2009.06.043_bib6 article-title: Highly active antiretroviral therapy improves neurocognitive functioning publication-title: J Acquir Immune Defic Syndr doi: 10.1097/00126334-200405010-00003 – volume: 360 start-page: 1808 issue: 18 year: 2009 ident: 10.1016/j.jns.2009.06.043_bib30 article-title: Rationing antiretroviral therapy in Africa—treating too few, too late publication-title: N Engl J Med doi: 10.1056/NEJMp0902820 – volume: 69 start-page: 1789 year: 2007 ident: 10.1016/j.jns.2009.06.043_bib35 article-title: Updated research nosology for HIV-associated neurocognitive disorders publication-title: Neurology doi: 10.1212/01.WNL.0000287431.88658.8b – volume: 507 year: 2004 ident: 10.1016/j.jns.2009.06.043_bib26 article-title: Neurocognitive impairment and survival in HIV-positive patients treated with HAART: results from an urban observational cohort publication-title: Eleventh Conference on Retroviruses and Opportunistic Infections, San Francisco, abstract – volume: 19 start-page: 1367 year: 2005 ident: 10.1016/j.jns.2009.06.043_bib19 article-title: The International HIV Dementia scale: a new rapid screening test for HIV dementia publication-title: AIDS – volume: 1152 year: 2006 ident: 10.1016/j.jns.2009.06.043_bib7 article-title: Salvage therapy with abacavir and other reverse transcriptase inhibitors for human imunodeficiency-associated encephalopathy publication-title: Pediatr Infect Dis J 25, 1142– – volume: 23 start-page: 1475 issue: 11 year: 2003 ident: 10.1016/j.jns.2009.06.043_bib21 article-title: Management of anemia of chronic disease in patients with the human immunodeficiency virus publication-title: Pharmacotherapy doi: 10.1592/phco.23.14.1475.31949 – volume: 17 start-page: 180 year: 2005 ident: 10.1016/j.jns.2009.06.043_bib33 article-title: The relationship between age and cognitive function in HIV-infected men publication-title: J Neuropsychiatry Clin Neurosci doi: 10.1176/jnp.17.2.180 – volume: 63 start-page: 822 issue: 3 year: 2004 ident: 10.1016/j.jns.2009.06.043_bib34 article-title: Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort publication-title: Neurology doi: 10.1212/01.WNL.0000134665.58343.8D |
SSID | ssj0006889 |
Score | 2.1397622 |
Snippet | The prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk factors. The... AbstractBackgroundThe prevalence of HIV-associated neurocognitive disorders (HAND), especially HIV-associated dementia (HAD) is influenced by several risk... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 149 |
SubjectTerms | Acquired immune deficiency syndrome Adolescent Adult Africa South of the Sahara - epidemiology AIDS Dementia Complex - blood AIDS Dementia Complex - epidemiology AIDS Dementia Complex - immunology Biological and medical sciences Cameroon Cameroon - epidemiology CD4 Lymphocyte Count Cognition Disorders - blood Cognition Disorders - epidemiology Cognition Disorders - immunology Cross-Sectional Studies Dementia Female Hemoglobins - metabolism HIV Infections - blood HIV Infections - epidemiology HIV Infections - immunology HIV/AIDS Human immunodeficiency virus Human viral diseases Humans IHDS Infectious diseases Male Medical sciences Middle Aged Neurology Prevalence Risk Factors Severity of Illness Index SSA Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids Young Adult |
Title | Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: The case of Yaoundé-Cameroon |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0022510X09006868 https://www.clinicalkey.es/playcontent/1-s2.0-S0022510X09006868 https://dx.doi.org/10.1016/j.jns.2009.06.043 https://www.ncbi.nlm.nih.gov/pubmed/19631349 https://www.proquest.com/docview/20829645 https://www.proquest.com/docview/734041568 https://pubmed.ncbi.nlm.nih.gov/PMC4906943 |
Volume | 285 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELb6kBASQrwJj8UHDoCU1omd2Oa2Wqi2oO4BKFpOlmM7Im3Jrsjulf_D7-CP4UmcwEJbJK6JJ4ntz-NxZuYbhJ5mWguTCagR5o8ojJgkFiWTsRV5aYQTecEh3_lolk-P2Zt5Nt9Ckz4XBsIqg-7vdHqrrcOV_TCa-8uqghxfj8WEzIls8xzENtpNqcw9tHfHh2-ns0Eh50LInjQcBHrnZhvmdVI3gbUy3yOMXrQ9XVvqxg9a2VW7OM8c_TOq8rdt6uAGuh7sSzzuunATbbn6FrpyFDzot9HqXdWc4lBlB3uLFU8PP8Y6TJKzuCW4HIKKsA3snA1-Nh3PXj3HVY2bdRG_18D0XOOuztBL7OGGjd8R8aLEnzTUavrxPZ7oL85b5vUddHzw-sNkGofKC7HxFssqFkyWhuiSuZIUpWWaGX-uE84UjDuZOJcWliaWc50WPEu5yx23RWLzjJaEak7vop16Ubv7CEuSaWuohV-NzMLca25Z7oWpJUWWRoj0A65MoCWH6hhnqo8_O1F-jqBcplQQg8dohF4MIsuOk-Oyxmk_i6pPNvXqUfkd4zIhfp6Qa8ICb1SimlQR9RcII8QGyQ0c_-uFow2ADf3y1hvjUrIIPekRp7wCAK-Ort1iDU8R4DrPIoQvaMEpAyIG-Lh7HUR_DZvXv0BQ6Tu8Ad6hAbCPb96pq88tCzmTkDNNH_xfhx-iq61fDmKDskdoZ_V17R57825VjND23rdkFBbxT_-OUMk |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZKkQAJIf4JP60PHAAprRM7sc2tWqi20N0DtGg5WY7tiBTIrsjulffhOXgxPImTstAWiWviSTL2zHicmfkGoaeZ1sJkAnqE-SMKIyaJRclkbEVeGuFEXnCod55M8_ExezPLZhto1NfCQFplsP2dTW-tdbiyG2Zzd1FVUOPrZTEhMyLbOgdxCV1mXn1BO3e-n-Z55ELIHjIchvehzTbJ66RuAmZlvkMYPW9zur7QjZ-ysut1cZYz-mdO5W-b1P5NdCN4l3ivY-AW2nD1bXRlEuLnd9DyXdV8xqHHDvb-Kh4ffIh1WCJncQtvOaQUYRuwORv8bLw3ffUcVzVuVkX8XgPOc427LkMvsRc2bPx-iOcl_qihU9PPH_FIf3XeL6_vouP910ejcRz6LsTG-yvLWDBZGqJL5kpSlJZpZvypTjhTMO5k4lxaWJpYznVa8CzlLnfcFonNM1oSqjm9hzbree0eICxJpq2hFn40Mgsrr7lluSemlhRZGiHST7gyAZQcemN8UX322YnyawTNMqWCDDxGI_RiIFl0iBwXDU77VVR9qak3jsrvFxcR8bOIXBPUu1GJalJF1F8iGCE2UK5J8b9euLUmYANf3ndjXEoWoe1e4pRXf4jp6NrNV_AUAYHzLEL4nBGcMoBhgI-734no6bR56wvwlJ7hNeEdBgD2-PqduvrUYpAzCRXT9OH_MbyNro6PJofq8GD69hG61kboIEsoe4w2l99W7ol39JbFVqvIvwDNPlGN |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Risk+factors+for+HIV%E2%80%95associated+neurocognitive+disorders+%28HAND%29+in+sub%E2%80%95Saharan+Africa%3A+The+case+of+Yaound%C3%A9%E2%80%95Cameroon&rft.jtitle=Journal+of+the+neurological+sciences&rft.au=NJAMNSHI%2C+A.+K&rft.au=ZOUNG-KANYI+BISSEK%2C+A.+C&rft.au=NJAMNSHI%2C+D.+M&rft.au=KOUANFACK%2C+C&rft.date=2009-10-15&rft.pub=Elsevier&rft.issn=0022-510X&rft.volume=285&rft.issue=1-2&rft.spage=149&rft.epage=153&rft_id=info:doi/10.1016%2Fj.jns.2009.06.043&rft.externalDBID=n%2Fa&rft.externalDocID=22347994 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0022510X%2FS0022510X09X00109%2Fcov150h.gif |